Fidaxomicin resistance in Clostridioides difficile : a systematic review and predictive modeling with RNA polymerase binding sites
Antimicrobial Agents and Chemotherapy · 05.12.2024 · 68 (12)
DOI: 10.1128/aac.01206-24 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 05.12.2024. Verfasst von ThanhPhuong M Le und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA. Hauptthemen laut MEDLINE: Fidaxomicin, Clostridioides difficile, DNA-Directed RNA Polymerases, Microbial Sensitivity Tests. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID).
Abstract (Originalsprache)
Fidaxomicin (FDX), an RNA polymerase (RNAP) inhibitor antibiotic, is a guideline-recommended therapy for Clostridioides difficile infection. Mutations associated with reduced FDX minimum inhibitory concentrations (MICs) have been identified. However, the molecular characterization of these mutations on FDX binding and the development of FDX resistance have not been studied. The purpose of this systematic review was to identify FDX resistance in C. difficile isolates and determine whether single nucleotide polymorphisms associated with increased FDX MIC aligned with the RNAP binding pocket interacting residues. A systematic literature search was done in PubMed (1991–2023) with identified articles and their bibliographies searched for papers that included C. difficile genetic mutations and increased FDX MIC. Visualization of FDX-RNAP interactions was performed on Schrödinger Maestro using the publicly available C. difficile RNAP with fidaxomicin sequence (code 7L7B) on the Protein Data Bank. Seven articles were identified after applying inclusion and exclusion criteria. The most common mutation in clinical and laboratory isolates was at position V1143 of the β subunit, which accounted for approximately 50% of the identified mutations. Most other mutations occurred within the β′ subunit of RNAP. Approximately one-third of the identified mutation aligned directly with FDX interacting residues with C. difficile RNAP (7/20) with most of the remainder occurring within 5 Å of the binding residues. C. difficile strains with elevated FDX MIC align closely with the known RNAP binding residues. These data demonstrate the potential to identify genomic methods to identify emerging FDX resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, Texas, USA.
- Department of Translational Medical Sciences, Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas, USA.
- Department of Microbiology, UT Southwestern Medical Center, Dallas, Texas, USA.
ORCID-Profile: ThanhPhuong M Le, Taryn A Eubank, Ann M McKelvey, Xinyun Cao, Julian G Hurdle, Kevin W Garey
Förderung
- NIAID NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
Zitieren
APA
Le, T. M., Eubank, T. A., McKelvey, A. M., Cao, X., Hurdle, J. G., & Garey, K. W. (2024). Fidaxomicin resistance in Clostridioides difficile : a systematic review and predictive modeling with RNA polymerase binding sites. Antimicrobial Agents and Chemotherapy, 68(12). https://doi.org/10.1128/aac.01206-24
Vancouver
Le TM, Eubank TA, McKelvey AM, Cao X, Hurdle JG, Garey KW. Fidaxomicin resistance in Clostridioides difficile : a systematic review and predictive modeling with RNA polymerase binding sites. Antimicrobial Agents and Chemotherapy. 2024;68(12). doi:10.1128/aac.01206-24
BibTeX
@article{Le2024,
author = {Le, ThanhPhuong M and Eubank, Taryn A and McKelvey, Ann M and Cao, Xinyun and Hurdle, Julian G and Garey, Kevin W},
title = {Fidaxomicin resistance in Clostridioides difficile : a systematic review and predictive modeling with RNA polymerase binding sites},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
volume = {68},
number = {12},
doi = {10.1128/aac.01206-24}
}
EUVIMED